KinetiCor Names Twenty-One Year Veteran of GE and GE Healthcare, Michael Jones, as Chairman of its Business Advisory Board
February 17, 2020 02:00 ET
|
KinetiCor
SAN DIEGO, Feb. 17, 2020 (GLOBE NEWSWIRE) -- KinetiCor, Inc., today’s only FDA 510(k) cleared optical motion detection solution1 for advanced Magnetic Resonance Imaging (MRI) scanners, is pleased to...
Breast Biopsy Device Market To Reach USD 1.37 Billion By 2026 | Reports And Data
October 09, 2019 10:11 ET
|
Reports and Data
New York, Oct. 09, 2019 (GLOBE NEWSWIRE) -- High prevalence of breast cancer, increasing awareness, innovative product launches, increasing strategic developments such as partnerships and...
FONAR Announces Year-End Earnings For Fiscal 2019
September 13, 2019 16:35 ET
|
Fonar Corporation
Cash and cash equivalents and Short term investments increased by 48% to $29.0 million during the fiscal year ended June 30, 2019.Total Revenues-Net increased by 7% to $87.2 million for the fiscal...
Delaware Imaging Network Offers New Brain Imaging Software in Delaware
August 29, 2019 10:00 ET
|
RadNet, Inc.
NEWARK, Del., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Delaware Imaging Network (DIN), Delaware’s largest network of outpatient medical imaging centers, which is a division of RadNet, Inc. (NASDAQ:RDNT), a...
FONAR Announces Fiscal 2019 3rd Quarter and Nine-Months Financial Results
May 13, 2019 07:00 ET
|
Fonar Corporation
Total Revenues – Net increased 9% to $22.8 million, for the third quarter and 7% to $64.7 million for the nine-month period ended March 31, 2019, versus same period during prior year.Income from...
FONAR Announces Annual Meeting and Shareholder Letter
April 10, 2019 08:00 ET
|
Fonar Corporation
MELVILLE, N.Y., April 10, 2019 (GLOBE NEWSWIRE) -- FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported today it is holding its annual shareholder meeting on May 20, 2019, in...
Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 21, 2019 16:30 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that on February 19, 2019, the Compensation Committee...
FONAR Announces Fiscal 2019 2nd Quarter and Six Months Financial Results
February 11, 2019 07:00 ET
|
Fonar Corporation
Total Revenues – Net, increased 6% to $41.9 million, for the six month period ended December 31, 2018, versus same six month period during prior year.Income from Operations increased 9% to $11.5...
Celsion Corporation to Present at NobleConXV – Noble Capital Markets’ 15th Annual Investor Conference
January 24, 2019 11:30 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Jeffrey Church, Celsion’s Executive Vice...
Celsion Announces Publication of ThermoDox® Study Results in Radiology
January 17, 2019 08:30 ET
|
Celsion CORP
Publication Highlights Phase I Data Supporting Safety and Feasibility of Treatment with ThermoDox® and Non-Invasive, Focused Ultrasound University of Oxford’s Findings Provide Additional...